北京市冬季公共场所室内空气中TSP, PM10, PM2.5和PM1污染研究

在北京市的海淀区、朝阳区、丰台区和昌平区选择了 49个公共场所 (包括办公室、宾馆、图书馆、超市等等 ) ,分别对其室内空气中TSP ,PM10 ,PM2 5 和PM1的浓度进行了测定 ,并且对室内空气中粉尘含量的影响因素进行了分析和探讨 .研究结果表明 ,繁忙的交通状况和建筑施工将明显增加公共场所室内空气中TSP ,PM10 ,PM2 5 和PM1浓度 .频繁的室内清扫有助于降低室内空气中颗粒物的浓度 .在室内空气中 ,PM10 浓度与TSP浓度呈现明显的正向线性相关性 ,而PM2 5 和PM1的浓度与PM10 浓度的相关性较差     

西湖底泥不同供氧条件下有机质降解及CO2与CH4释放速率的模拟研究

采用密闭培养实验装置于室温（２５℃左右）及ｐＨ为７５条件下，对西湖底泥中有机质完全降解及转化为ＣＯ２和ＣＨ４的速率进行了模拟研究．结果表明，在西湖湖水现有供氧水平（５０—８６ｍｇ（Ｏ２）／Ｌ）条件下，底泥中有机质完全降解的速率最为缓慢，培养期间（４２天）平均只有０７２ｍｇ（Ｃ）／（ｋｇ·ｄ）．当湖水供氧水平进一步上升（８６→１２０→１６０ｍｇ（Ｏ２）／Ｌ），ＣＯ２释放速率增加，最大值可达到８７ｍｇ（Ｃ）／（ｋｇ·周）；当湖水供氧水平下降（８６→０ｍｇ（Ｏ２）／Ｌ），ＣＨ４释放速率加快，最大值可达到４６ｍｇ（Ｃ）／（ｋｇ·周）．     

乙醇废水的超临界水氧化反应路径及动力学研究

研究了超临界水氧化法 (SCWO)处理乙醇废水过程的反应路径和动力学 .乙醇SCWO反应的最终产物为CO2 ,CO是此过程的中间产物 .以幂指数方程描述乙醇SCWO反应动力学 ,得到对于乙醇的反应级数为 1,对氧气的反应级数为 0 .求出活化能和指前因子分别为 3 5 1× 10 5J·mol-1和 7 74× 10 2 1s-1.方程计算值和实验值吻合较好 ,误差基本在 10 %以内     

双循环流化床烟气悬浮脱硫技术工业化试验研究

在一台75t/h电站燃煤锅炉上，设计建造了基于双循环流化床烟气悬浮脱硫技术工艺的脱硫装置，烟气处理量为140000m^3/h，该脱硫装置主要特征是循环灰采用两经分离，内外双重循环方式和石灰浆液采用多层喷浆方式。介绍了该装置的系统组成、工作原理、工艺流程、工业化实验结果。实际表明：当Ca/S=1.3,△T=10℃时，脱硫效率达90%；固体颗粒物的循环使脱硫效率提高15%左右。     

再燃脱硝的动力学模拟和组分影响分析

采用Gear算法模拟了再燃脱硝再燃区中化学反应过程，反应的热力学和动力学参数采用GRI3．0,模拟结果和实验结果作比较，说明该模拟可以用于预测再燃脱硝的基本过程。在模拟的基础上讨论了不同再燃燃料及其中的不同组分如HCN、NH3、H2和CO等对脱硝效果的影响。     

有机磷酸酯诱导迟发性神经毒性及其对神经毒性酯酶(NTE)活性影响的动态研究

以成年产卵来航母鸡为试验动物，研究了三甲基苯基磷酸酯诱导的迟发性神经毒性。试验发现，母鸡口服ＴＯＣＰ后经过大约８－１０ｄ的潜伏期开始出现中毒症状，其表现为以步态失调为主要特征的运动障碍呈进行性加重，至２１ｄ开始便发展为瘫痪。     

Maternal age-specific risks for trisomies at 9—14 weeks' gestation

This study provides data on the incidence of fetal trisomies 21, 18, and 13 at 9–14 weeks' gestation in women aged 35–45 years and estimates of maternal age-specific risks in women aged 20–45 years. Our data from 5814 singleton pregnancies undergoing first-trimester karyotyping for the sole indication of maternal age ⩾ 35 years were combined with those from two previous reports and the incidence of the trisomies was calculated from a total of 15 793 pregnancies. Comparison of incidences at 9–14 weeks' gestation with published data at 15–20 weeks' gestation and in livebirths demonstrated that at birth the maternal age-specific incidence of trisomy 21 is 33 per cent lower than at 15–20 weeks' gestation and 54 per cent lower than at 9–14 weeks' gestation. Furthermore, the relative frequency of trisomies 18 and 13 decreases from 30 per cent at 9–14 weeks to 22 per cent at 15–20 weeks and 14 per cent at birth.     

MSAFP levels and oesophageal atresia

This study was undertaken to evaluate the relationship between maternal serum alpha-fetoprotein (MSAFP) levels and oesophageal atresia (OA). OA occurred in 16 fetuses of mothers who had an MSAFP test in the study interval. The multiple of the median (MOM) value for MSAFP averaged 1·54 ± 0·65 (range 0·5–2·9 MOM), which was significantly higher than the value seen in controls. The median MOM was 1·35. Using a cut-off of 2·5 MOM, the sensitivity of MSAFP for detecting OA was 19 per cent. Although OA should be considered in the differential diagnosis of an elevated MSAFP level, MSAFP cannot be considered an appropriate screening test for OA given the low sensitivity.     

发光细菌对化合物的致突效应与检测研究

从明亮发光杆菌Ｔ３小种分离到的自发暗变种（Ｋ变种）Ｔ９１７１菌种对三种化合物呈致空变阳性反应，对二种化合物呈可疑阳性，发光细菌暗变种对遗传毒性化合物致突效应的灵敏度高于Ａｍｅｓ试验和浦乳动物致癌试验，可望成为一种简易灵敏的测试环境致突变物的短期生物学试验方法。     

Expanding multiple marker screening for Down's syndrome to include Edward'S syndrome

Information on maternal age and maternal serum alpha-fetoprotein, unconjugated oestriol (uE₃), and human chorionic gonadotrophin (hCG) levels was used to investigate retrospectively the effect of estimating Edward's syndrome risk in women having multi-marker screening for Down's syndrome. The screened population comprised 15 pregnancies affected by Edward's syndrome, 15 with Down's syndrome and 5472 unaffected pregnancies. The use of all three markers to estimate Edward's syndrome risk would have led to the detection of 10–12 (67–80 per cent) cases with a false-positive rate of 0.3–0.6 per cent depending on the risk cut-off. A further case would have been detected as a result of screening for Down's syndrome alone. Similar results were obtained when the Edward's syndrome risk was based on uE₃ and hCG only. These data suggest that extending Down's syndrome screening to include Edward's syndrome risk will yield a high detection rate with only a small increase in the false-positive rate.